Cigar Industry Associations File Suit Against FDA
When the FDA Deeming Regulations were announced, Thompson Cigar, like most Cigar Industry companies, paused to consider the ramifications for our customers of the sweeping regulations. Just what the final form of the regulations will look like became a little less clear on July 15.
We are members of all three associations that jointly filed a lawsuit on that day asking that the regulations be vacated. We fully support this action and hope the Court will issue a declaratory injunction quickly. We believe the FDA has overreached and violated numerous statutes as well as the federal rulemaking process in their attempt to limit your rights and ours.
Here’s the full announcement of the suit and links to more information:
Major cigar and tobacco industry associations file suit against FDA’s deeming rule
~ CAA, IPCPRA, & CRA ask District Court of Washington D.C. for declaratory injunction ~
"Just over one month ago, our three associations pledged to work together to develop the appropriate response to the FDA’s new deeming rule. After a thorough and detailed legal review, we are challenging this unlawful regulatory action in federal court to protect the statutory and constitutional rights of our industry and its members. The fact that all three of our organizations are acting in once voice speaks to the urgency and seriousness of this action," said Mark Pursell, CEO of the International Premium Cigar and Pipe Retailers Association.
The complaint challenges:
FDA’s improper application of the February 15, 2007 grandfather date to cigars and pipe tobacco, which subjects those products to more intrusive regulations than cigarettes and smokeless tobacco
FDA’s impermissible assessment of a tax in the form of user fees, and its allocation of these user fees only to cigars and pipe tobacco and not to other newly deemed products
FDA’s failure to perform an adequate cost-benefit analysis to take into account the effects of the Final Rule on small businesses as is required by the Regulatory Flexibility Act
FDA’s unjustified decision to require cigar health warning labels to be 30% of the two principal display panels of packages
FDA’s unlawful designation of tobacconists who blend finished pipe tobacco or create cigar samplers of finished cigars as "manufacturers," which subjects those businesses to greater regulation than if they were "retailers”
FDA’s incorrect decision to regulate pipes as "components” or "parts” rather than as "accessories”
"The FDA ignored the law to craft these expansive and sweeping regulations and cannot justify many of the arbitrary and capricious regulations it purports to enact," said Glynn Loope, Executive Director of Cigar Rights of America. "This lawsuit is a specific and detailed challenge to the FDA’s unprecedented assertion of rulemaking authority. We are acting in one voice to protect the legal rights of our industry at all levels, from the manufacturer, the community retail tobacconist, to the adult patrons of cigars."
Speaking about the lawsuit, Cigar Association of America President Craig Williamson said, "We all worked in good faith to inform and educate the FDA on the unique nature of our industry, its members, and our consumers. We hoped the FDA would craft a flexible regulatory structure that accounted for the uniqueness of our industry. Instead, we got a broad, one-size-fits-all rule that fails to account for how cigars and premium cigars are manufactured, distributed, sold and consumed in the United States. The FDA exceeded its statutory authority and violated the federal rulemaking process when crafting this set of broad and sweeping regulations. This challenge asserts nine violations of federal law and rulemaking authority. We are asking the court to enjoin the enforcement of this unlawful regulatory scheme. We are confident that when the court reviews our case on its merits, we will prevail."
To review Halfwheel’s guide to the FDA regulation of cigars, please click here
To get more information on the Cigar Industry lawsuit, please contact:
Cigar Association of America
International Premium Cigar and Pipe Retailers Association
Cigar Rights of America
FDA Regulation on Cigars
On May 5, 2016 The U.S. Food & Drug Administration (FDA) announced its plans to regulate deemed tobacco products, extending its authority to include cigars. Barring an injunction from a court or Congressional review, the new rules will go into effect on Aug. 8, 2016.
Here’s what you need to know about the new regulations:
Cigars that were marketed before February 15, 2007 are grandfathered and exempt from FDA regulation
Cigars marketed between February 16, 2007 and August 8, 2016 will remain on the market but must be submitted to the FDA within 2 years
Cigars marketed after August 8, 2016 will require FDA approval prior to being released to market
Cigars submitted to the FDA could take up to one year to be approved or denied
The cost and timeline of approval has yet to be announced; however, the cost is estimated in a range of up to $300,000 per application
The FDA issued additional restrictions including:
warning label requirements on all packaging (boxes, bundles, samplers or packs)
requirements for warning labels to be present a specific distance away from the display and at point of purchase for single stick cigars
mandatory warnings used in advertising and media
a ban on free cigar sampling
Enforcing age restriction on all cigar transactions including the requirement for a government-issued photo id
Thompson Cigar is committed to providing our customers with the best experience possible and is carefully analyzing these new regulations to lessen the impact on our customers.